Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.01), MarketWatch Earnings reports. Sonoma Pharmaceuticals had a negative return on equity of 71.86% and a negative net margin of 50.75%. The company had revenue of […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 41,500 shares, an increase of 15.9% from the September 30th total of 35,800 shares. Based on an average daily volume of 25,400 shares, […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Free Report) was the target of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 82,100 shares, a decrease of 71.5% from the June 15th total of 287,700 shares. Based on an average daily trading volume, of 510,400 […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Rating) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.20 and traded as high as $1.37. Sonoma Pharmaceuticals shares last traded at $1.24, with a volume of 1,211,783 shares changing hands. Sonoma Pharmaceuticals […]
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA – Get Rating) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.20 and traded as high as $1.37. Sonoma Pharmaceuticals shares last traded at $1.24, with a volume of 1,211,783 shares changing hands. Sonoma Pharmaceuticals […]